| Size & multiples | |||
| Market Cap | $169.8M | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 48.54× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | −15.46% | Buyback Yield | — |
| Owner Earnings (TTM) | -$84.5M | Owner Earnings Yield | −49.79% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 19.46 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 101.30% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted), Revenue · EPS TTM -$2.65 · revenue TTM $3.5M · FCF TTM -$26.2M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -17.6% | -7.9% | -35.6%–1.4% | 37 ↓weak |
| Net Margin | -2298.5% | -21.2% | -325.3%–7.2% | 12 ↓weak |
| Operating Margin | -1502.4% | -34.5% | -552.0%–8.0% | 17 ↓weak |
| ROE | -145.1% | -36.8% | -92.5%–4.5% | 15 ↓weak |
